FTC probing middlemen's role in drug shortages

The Federal Trade Commission is exploring how drug distributors and group-purchasing organizations may be contributing to ongoing shortages of generic drugs at health care facilities.

Why it matters: It's the latest effort to untangle a complex web of factors driving high levels of shortages in the United States, which have affected cancer drugs and antibiotics, among others.